 |
Size ($ in 1000's)
At 12/31/2023: $624,986
At 09/30/2023: $650,906
Octagon Capital Advisors LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Octagon Capital Advisors LP 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, below is a summary of the Octagon Capital Advisors LP top holdings by largest position size, as per the latest 13f filing made by Octagon Capital Advisors LP.
In the Octagon Capital Advisors LP-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares
held by Octagon Capital Advisors LP in that top holding, then the share count change between reporting periods, and finally the Octagon Capital Advisors LP top holding position size
for that row.
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
|---|
| APELLIS PHARMACEUTICALS INC |
2,806,980 |
-48,020 |
$168,026 | | APLS | 2,806,980 | -323,020 | $168,026 | | CYMABAY THERAPEUTICS INC |
2,673,750 |
-340,000 |
$63,154 | | CBAY | 2,673,750 | -400,000 | $63,154 | | VERONA PHARMA PLC |
2,369,000 |
UNCH |
$47,096 | | VRNA | 2,369,000 | UNCH | $47,096 | | INSMED INC |
1,284,000 |
UNCH |
$39,791 | | INSM | 1,284,000 | UNCH | $39,791 | | ARCUS BIOSCIENCES INC |
1,868,000 |
-100,000 |
$35,679 | | RCUS | 1,868,000 | -100,000 | $35,679 | | BRIDGEBIO PHARMA INC |
706,800 |
-264,839 |
$28,534 | | BBIO | 706,800 | -264,839 | $28,534 | | CELLDEX THERAPEUTICS INC NEW |
707,526 |
-52,372 |
$28,060 | | CLDX | 707,526 | -52,372 | $28,060 | | ROIVANT SCIENCES LTD |
2,494,000 |
-1,873,000 |
$28,008 | | ROIV | 2,494,000 | -1,873,000 | $28,008 | | ALPINE IMMUNE SCIENCES INC |
1,241,300 |
+491,300 |
$23,659 | | ALPN | 1,241,300 | +491,300 | $23,659 | | STRUCTURE THERAPEUTICS INC |
414,000 |
+414,000 |
$16,875 | | GPCR | 414,000 | +414,000 | $16,875 | | CENTESSA PHARMACEUTICALS PLC |
2,060,100 |
+1,584,500 |
$16,398 | | CNTA | 2,060,100 | +1,584,500 | $16,398 | | AN2 THERAPEUTICS INC |
664,575 |
-203,000 |
$13,617 | | ANTX | 664,575 | -203,000 | $13,617 | | VIRIDIAN THERAPEUTICS INC |
620,000 |
-447,143 |
$13,504 | | VRDN | 620,000 | -447,143 | $13,504 | | IMMUNOVANT INC |
273,289 |
+1,273,289 |
$11,514 | | IMVT | 273,289 | +273,289 | $11,514 | | DYNE THERAPEUTICS INC |
792,945 |
+100,000 |
$10,546 | | DYN | 792,945 | +100,000 | $10,546 | | CYTOKINETICS INC |
116,000 |
+116,000 |
$9,685 | | CYTK | 116,000 | +116,000 | $9,685 | | ANNEXON INC |
2,050,000 |
UNCH |
$9,307 | | ANNX | 2,050,000 | UNCH | $9,307 | | AEROVATE THERAPEUTICS INC |
403,685 |
-93,685 |
$9,135 | | AVTE | 403,685 | -93,685 | $9,135 | | GOSSAMER BIO INC |
9,187,883 |
+1,000,000 |
$8,384 | | GOSS | 9,187,883 | +1,000,000 | $8,384 | | RAPT THERAPEUTICS INC |
292,000 |
+292,000 |
$7,256 | | RAPT | 292,000 | +292,000 | $7,256 | | GLYCOMIMETICS INC |
3,000,000 |
UNCH |
$7,080 | | GLYC | 3,000,000 | UNCH | $7,080 | | GRACELL BIOTECHNOLOGIES INC |
596,611 |
+596,611 |
$5,990 | | GRCL | 596,611 | +596,611 | $5,990 | | DIANTHUS THERAPEUTICS INC |
554,000 |
+74,000 |
$5,762 | | DNTH | 554,000 | +74,000 | $5,762 | | RENEO PHARMACEUTICALS INC |
2,250,000 |
-29,870 |
$3,600 | | RPHM | 2,250,000 | -29,870 | $3,600 | | JASPER THERAPEUTICS INC |
4,468,114 |
UNCH |
$3,525 | | JSPR | 4,468,114 | UNCH | $3,525 | | VERU INC |
3,800,000 |
+3,800,000 |
$2,736 | | VERU | 3,800,000 | +3,800,000 | $2,736 | | ANAPTYSBIO INC |
120,000 |
+120,000 |
$2,570 | | ANAB | 120,000 | +120,000 | $2,570 | | INOZYME PHARMA INC |
400,000 |
-900,000 |
$1,704 | | INZY | 400,000 | -900,000 | $1,704 | | NUVATION BIO INC |
1,000,000 |
+1,000,000 |
$1,510 | | NUVB | 1,000,000 | +1,000,000 | $1,510 | | XILIO THERAPEUTICS INC |
1,785,000 |
-533,500 |
$982 | | XLO | 1,785,000 | -533,500 | $982 | | MIRUM PHARMACEUTICALS INC |
25,000 |
+25,000 |
$738 | | MIRM | 25,000 | +25,000 | $738 | | PHATHOM PHARMACEUTICALS INC |
50,000 |
+50,000 |
$456 | | PHAT | 50,000 | +50,000 | $456 |
See Full List: All Stocks Held By Octagon Capital Advisors LP
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By Octagon Capital Advisors LP
|
|
